Add to ORKGIn vitro assessment of drug-drug interaction potential of boceprevir associated with drug metabolizing enzymes and transporter
Introduction: Boceprevir was the first direct acting agent developed for the treatment of hepatitis ...
LR: 20041117; PUBM: Print; JID: 7905878; 0 (Pharmaceutical Preparations); CON: Rev Infect Dis. 1991 ...
Boceprevir is a hepatitis C virus (HCV) nonstructural protein (NS) 3/4A protease inhibitor that is c...
ABSTRACT The inhibitory effect of boceprevir (BOC), an inhibitor of hepatitis C virus nonstructural ...
Purpose. Chronic hepatitis C virus (HCV) is a major problem affecting up to 170 million people world...
This article h s not been copyedited and formatted. The final version may differ from this version
strasbourg.fr Abstract: Boceprevir was the first agent, along with telaprevir, of a novel class of d...
This article has not been copyedite and formatted. The final versi n may differ fro this version
Background. Patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) ...
This article has not been copyedited and formatted. The final version may differ from this version
OBJECTIVES: Proton pump inhibitors (PPIs) can limit the solubility of concomitant drugs, which can l...
Boceprevir is a NS3/4A hepatitis C virus (HCV) protease inhibitor, used in combination with peginter...
Background and Aims Clinical trials of therapy against chronic hepatitis C virus (HCV) infection inc...
BACKGROUND: Patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) ...
Background: St John’s wort (SJW; Hypericum perforatum) induces CYP3A4 that is involved in the metabo...
Introduction: Boceprevir was the first direct acting agent developed for the treatment of hepatitis ...
LR: 20041117; PUBM: Print; JID: 7905878; 0 (Pharmaceutical Preparations); CON: Rev Infect Dis. 1991 ...
Boceprevir is a hepatitis C virus (HCV) nonstructural protein (NS) 3/4A protease inhibitor that is c...
ABSTRACT The inhibitory effect of boceprevir (BOC), an inhibitor of hepatitis C virus nonstructural ...
Purpose. Chronic hepatitis C virus (HCV) is a major problem affecting up to 170 million people world...
This article h s not been copyedited and formatted. The final version may differ from this version
strasbourg.fr Abstract: Boceprevir was the first agent, along with telaprevir, of a novel class of d...
This article has not been copyedite and formatted. The final versi n may differ fro this version
Background. Patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) ...
This article has not been copyedited and formatted. The final version may differ from this version
OBJECTIVES: Proton pump inhibitors (PPIs) can limit the solubility of concomitant drugs, which can l...
Boceprevir is a NS3/4A hepatitis C virus (HCV) protease inhibitor, used in combination with peginter...
Background and Aims Clinical trials of therapy against chronic hepatitis C virus (HCV) infection inc...
BACKGROUND: Patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) ...
Background: St John’s wort (SJW; Hypericum perforatum) induces CYP3A4 that is involved in the metabo...
Introduction: Boceprevir was the first direct acting agent developed for the treatment of hepatitis ...
LR: 20041117; PUBM: Print; JID: 7905878; 0 (Pharmaceutical Preparations); CON: Rev Infect Dis. 1991 ...
Boceprevir is a hepatitis C virus (HCV) nonstructural protein (NS) 3/4A protease inhibitor that is c...